scholarly journals THE CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM. SPECIFIC PRECIPITATE EXTRACTS

1915 ◽  
Vol 22 (2) ◽  
pp. 248-268 ◽  
Author(s):  
Henry T. Chickering

1. The protective substances contained in specific precipitates from antipneumococcus serum can be extracted by suitable chemical and physical agents, dilute sodium carbonate at 42°C. being especially advantageous as an extractive agent. 2. The resulting water-clear extracts, when made up to the original volume of the serum used for precipitation, protect animals almost as well as does the whole serum. 3. The bacterial extracts used in precipitating the protective substances from the serum act specifically; that is, a bacterial extract of pneumococcus of Type I removes the protective substances from a Type I immune serum only. 4. In a polyvalent serum of Type I and Type II, the protective substances of each type may be removed independently of each other by the successive addition of the homologous antigens. 5. Extracts of specific serum precipitates contain only one-fiftieth to one-sixtieth of the protein in the original serum, and about one-half the protein of the whole precipitate. 6. Extracts contain not only protective substances but agglutinins and precipitins. 7. Extracts and whole precipitates not only confer passive immunity but stimulate the production of active immunity to pneumococcus infection in rabbits and mice.

1966 ◽  
Vol 64 (2) ◽  
pp. 129-175 ◽  
Author(s):  
Fred Griffith

1. In the course of the examination of sputum from cases of lobar pneumonia, observations have been made on the incidence of the chief types of pneumococci. In the district from which the material was obtained, there was an apparent local diminution in the number of cases of lobar pneumonia due to Type II; the figures were 32·6 per cent. of Type II cases in the period 1920–22, and only 7·4 per cent. in the period 1924–27. The incidence of Type I was approximately the same in the two periods, the percentages being 30·6 and 34·3.2. Several different serological varieties of pneumococci have been obtained from the sputum of each of several cases of pneumonia examined at various stages of the disease. This has occurred most frequently in cases of pneumonia due to Type I, and in two instances four different types of Group IV were found in addition to the chief types. The recovery of different types is facilitated by the inoculation of the sputum (preserved in the refrigerator), together with protective sera corresponding to the various types in the order of their appearance.3. Two interesting strains of Group IV pneumococci have been obtained from pneumonic sputum.One was an R strain which produced typical rough colonies, yet preserved its virulence for mice and its capacity to form soluble substance. This R pneumococcus developed a large capsule in the mice, which died of a chronic type of septicaemia. A strain producing smooth colonies was obtained from it in the course of a prolonged series of passage experiments.The second strain, which was proved not to be a mixture, agglutinated specifically with the sera of two different types. In the peritoneal cavity of the mouse the specific soluble substance of each type was produced.4. A method of producing the S to R change through ageing of colonies on chocolate blood medium containing horse serum is described. After two to three days' incubation small rough patches appear in the margins of the smooth colonies, and from these pure R strains can be isolated.5. It has been shown that the R change is not equally advanced in the descendants of virulent pneumococci which have been exposed to the action of homologous immune serum. Some R strains form traces of soluble substance in the peritoneal cavity of the mouse; these revert readily to the virulent S form and, in addition, are able to produce active immunity. Others show no evidence of S antigen; spontaneous reversion takes place with difficulty, if at all, and they are incapable of producing active immunity. The stronger the immune serum used, the more permanent and complete is the change to the R form.6. Restoration of virulence to an attenuated R strain, with recovery of the S form of colony and of the original serological type characters may be obtained by passage through mice. The change from the R to the S form is favoured by the inoculation of the R culture in large doses into the subcutaneous tissues; but the most certain method of procuring reversion is by the inoculation of the R culture, subcutaneously into a mouse, together with a large dose of virulent culture of the same type killed by heat.Incubation of such a mixture in vitro does not induce reversion.7. Reversion of an R strain to its S form may occasionally be brought about by the simultaneous inoculation of virulent culture of another type, especially when this has been heated for only a short period to 60° C., e.g. R Type II to its S form when inoculated with heated Type I culture.8. Type I antigen appears to be more sensitive to exposure to heat than Type II antigen, since the former loses the power to cause reversion when heated to 80° C, whereas Type II culture remains effective even after steaming at 100° C.9. The antigens of certain Group IV strains appear to be closely related to that of Type II, and are equally resistant to heat. Steamed cultures of these Group IV strains cause the R form derived from Type II to revert to its S form, while they fail to produce reversion of the R form derived from Type I.10. The inoculation into the subcutaneous tissues of mice of an attenuated R strain derived from one type, together with a large dose of virulent culture of another type killed by heating to 60° C., has resulted in the formation of a virulent S pneumococcus of the same type as that of the heated culture.The newly formed S strain may remain localised at the seat of inoculation, or it may disseminate and cause fatal septicaemia.The S form of Type I has been produced from the R form of Type II, and the R form of Type I has been transformed into the S form of Type II.The clear mucinous colonies of Type III have been derived both from the R form of Type I and from the R form of Type II, though they appear to be produced more readily from the latter. The newly formed strains of Type III have been of relatively low virulence, and have frequently remained localised at the subcutaneous seat of inoculation.Virulent strains of Types I and II have been obtained from an R strain of Group IV.11. Heated R cultures injected in large doses, together with small doses of living R culture have never caused transformation of type, and only rarely produced a reversion of the R form of Type II to its virulent S form.12. The results of the experiments on enhancement of virulence and on transformation of type are discussed and their significance in regard to questions of epidemiology is indicated.


1928 ◽  
Vol 27 (2) ◽  
pp. 113-159 ◽  
Author(s):  
Fred Griffith

1. In the course of the examination of sputum from cases of lobar pneumonia, observations have been made on the incidence of the chief types of pneumococci. In the district from which the material was obtained, there was an apparent local diminution in the number of cases of lobar pneumonia due to Type II the figures were 326 per cent. of Type II cases in the period 1920–22, and only 74 per cent. in the period 1924–27. The incidence of Type I was approximately the same in the two periods, the percentages being 3O6 and 343.2. Several different serological varieties of pneumococci have been obtained from the sputum of each of several cases of pneumonia examined at various stages of the disease. This has occurred most frequently in cases of pneumonia due to Type I, and in two instances four different types of Group IV were found in addition to the chief types. The recovery of different types is facilitated by the inoculation of the sputum (preserved in the refrigerator), together with protective sera corresponding to the various types in the order of their appearance.3. Two interesting strains of Group IV pneumococci have been obtained from pneumonic sputnm.One was an R strain which produced typical rough colonies, yet preserved its virnlence for mice and its capacity to form soluble substance. This R pneumococcus developed a large capsnle in the mice, which died of a chronic type of septicaemia. A strain producing smooth colonies was obtained from it in the course of a prolonged series of passage experiments.The second strain, which was proved not to be a mixture, agglutinated specifically with the sera of two different types. In the peritoneal cavity of the mouse the specific soluble substance of each type was produced.4. A method of producing the S to R change through ageing of colonies on chocolate blood medium containing horse serum is described. After two to three days' incubation small rough patches appear in the margins of the smooth colonies, and from these pure R strains can be isolated.5. It has been shown that the R change is not equally advanced in the descendants of virulent pneumococci which have been exposed to the action of homologous immune serum. Some R strains form traces of soluble substance in the peritoneal cavity of the mouse; these revert readily to the virulent S form and, in addition, are able to produce active immunity. Others show no evidence of S antigen; spontaneous reveraion takes place with difficulty, if at all, and they are incapable of producing active immunity. The stronger the immune serum used, the more permanent and complete is the change to the R form.6. Restoration of virulence to an attenuated R strain, with recovery of the S form of colony and of the original serological type characters may be obtained by passage through mice. The change from the R to the S form is favoured by the inoculation of the R culture in large doses into the subcutaneous tissues; but the most certain method of procuring reversion is by the inoculation of the R culture, subcutaneously into a mouse, together with a large dose of virulent culture of the same type killed by heat. Incubation of such a mixture in vitro does not induce reversion.7. Reversion of an R strain to its S form may occasionally be brought about by the simultaneous inoculation of virulent culture of another type, especially when this has been heated for only a short period to 60° 0., e.g. R Type II to its S form when inoculated with heated Type I culture.8. Type I antigen appears to be more sensitive to exposure to heat than Type II antigen, since the former loses the power to cause reversion when heated to 80° C., whereas Type II culture remains effective even after steaming at 100°C.9. The antigens of certain Group IV strains appear to be closely related to that of Type II, and are equally resistant to heat. Steamed cultures of these Group IV strains cause the R form derived from Type II to revert to its S form, while they fail to produce reversion of the R form derived from Type I.10. The inoculation into the subcutaneous tissues of mice of an attenuated R strain derived from one type, together with a large dose of virulent culture of another type killed by heating to 60° C., has resulted in the formation of a virulent S pneumococcus of the same type as that of the heated culture.Thp newly formed S strain may remain localised at the seat of inoculation, or it may disseminate and cause fatal septicaemia.The S form of Type I has been produced from the R form of Type II, and the R form of Type I has been transformed into the S form of Type II.The clear mucinous colonies of Type III have been derived both from the R form of Type I and from the R form of Type II, though they appear to be produced more readily from the latter. The newly formed strains of Type III have been of relatively low virulence, and have frequently remained localised at the subcutaneous seat of inoculation.Virulent strains of Types I and TI have been obtained from an R strain of Group IV.11. Heated R cultures injected in large doses, together with small doses of living R culture have never caused transformation of type, and only rarely produced a reversion of the R form of Type II to its virulent S form.12. The results of the experiments on enhancement of virulence and on transformation of type are discussed and their significance in regard to questions of epidemiology is indicated.


Active immunity to Brucella abortus was induced in adult female rabbits. They were mated a week after the last injection of antigen and were killed and the yolk-sac contents of the embryos tested for agglutinins 8½ days after copulation. Specific agglutinins were found to be present in the yolk-sac contents in all cases. The titre varied significantly from embryo to embryo in the same litter, and was in some as high as that in the maternal serum at the time of killing. Passive immunity to Br. abortus was imparted to female rabbits 7 to 9 days pregnant by intravenous injection of immune serum of high titre. The rabbits were killed and the yolk-sac fluid of the embryos tested for agglutinins 10 to 17 hr. after injection. Specific agglutinins were present in most of the embryos from five of the six rabbits injected before 8 days post-coitum. All the embryos in the sixth rabbit were regressing. Specific agglutinins were not found in any of the embryos from two rabbits injected after 9 days post-coitum, by which time the yolk-sac fluid has ceased to increase in volume. Positive results were obtained both when rabbit and bovine immune sera were used. Active immunity to Br. abortus was induced in pregnant rabbits by injections beginning after the 15th day post-coitum. The serum of the newborn young, removed from their immune mothers before they had suckled, was tested and specific agglutinins were found to be present with a titre corresponding to that of the maternal serum. It was concluded that agglutinins, whether actively or passively acquired, pass freely from the maternal circulation into the yolk-sacs of 7- and 8-day rabbit embryos. This constitutes a delicate test of the passage of protein without alteration through the yolk-sac wall. The yolk-sac wall does not appear to be selective, since it is at least as permeable to foreign proteins as it is to those of maternal origin. Agglutinins pass from the maternal circulation into the embryo after the disappearance of the bilaminar wall of the yolk-sac also, either by way of the yolk-sac splanchnopleur or the allantochorionic placenta or both. The bearing of these results on current theories of placental permeability are discussed.


1920 ◽  
Vol 32 (3) ◽  
pp. 283-293 ◽  
Author(s):  
Ida W. Pritchett

1. No demonstrable antiopsonins are formed in rabbits following the intravenous injection of monovalent pneumococcus horse sera, Types I, II, and III. 2. The serum of rabbits injected with immune pneumococcus horse serum, Type I, II, or III, or with normal horse serum, when mixed in the proportion of 1:4 with Type I or Type II pneumococcus horse serum, can greatly augment, in vitro, the opsonization and agglutination of Type I and Type II pneumococci by the homologous immune horse sera. No similar effect is obtained with Type III serum and pneumococci. 3. The increase in opsonization and agglutination is dependent upon (a) specific sensitization of the pneumococci by the homologous immune serum and (b) the presence of the precipitating serum. In the absence of sensitization, as when a heterologous or normal horse serum is employed, opsonization and agglutination do not occur, even though a precipitating mixture is provided. The substitution of normal rabbit serum for the precipitating rabbit serum gives opsonization and agglutination in dilutions slightly higher than are effected with salt solution only, due possibly to the more favorable medium created for the leucocytes by the addition of 25 per cent of whole rabbit serum. 4. Different methods of combining the immune horse serum, precipitating rabbit serum, and pneumococci yield very similar results, preliminary sensitization of the bacteria before precipitation, or precipitation in the rabbit-horse serum mixture before the addition of the pneumococci for sensitization causing little if any difference in result from that obtained when immune horse serum, precipitating rabbit serum, and pneumococci are all mixed and incubated together. 5. This increased opsonization in the test-tube does not seem to be paralleled by increased protective power, or at any rate such protection is not readily demonstrated.


1931 ◽  
Vol 54 (6) ◽  
pp. 875-898 ◽  
Author(s):  
Victor Ross

1. Considerable variation in the resistance of different rats toward Type II pneumococcus has been demonstrated. In general, older rats survive much greater doses than young ones, illustrating the acquisition of a natural partial immunity. The same is true for Type III but the immunity appears somewhat later in life and does not reach the same height. 2. An active immunity can be created against Types II and III in rats by feeding the dead organisms or the Berkefeld filtrate of the bile salt-dissolved cells. This immunity resembles that obtained against Type I in several respects.


1917 ◽  
Vol 26 (4) ◽  
pp. 537-561 ◽  
Author(s):  
Rufus Cole ◽  
Henry F. Moore

In the production of immune serum for therapeutic purposes strict attention must be paid to the immunological specificity of the bacteria used for immunization. At present the only serum of which the therapeutic value has been proven is that effective against Type I pneumococcus infection. This serum should have agglutinating power for Type I pneumococcus and should have the power of protecting mice against large amounts of virulent culture. Experiments have shown that for producing the primary immunity most rapidly several series of small doses of dead cultures should be given, the injections being made daily for 6 to 7 days, followed by a week in which no injections are made. To produce the highest type of immunity probably living organisms are required. These should be given in moderate doses daily for 3 days, with an interval of a week between each series of injections. By following accurately the methods described, horses may be made to produce rapidly a high grade of specific serum. The observations so far made indicate the importance of employing small doses of culture frequently repeated in this form of immunization.


1930 ◽  
Vol 51 (1) ◽  
pp. 99-122 ◽  
Author(s):  
Martin H. Dawson

R forms of Pneumococcus may be converted into S forms of the homologous Type. In addition to the methods previously reported,—(1) animal passage and (2) growth in anti-R sera,—conversion may be effected by the following procedures as employed by Griffith; (1) The subcutaneous injection, in white mice, of large amounts of living R organisms. (2) The subcutaneous injection, in white mice, of small amounts of living R organisms together with the heat-killed bacteria from large amounts of homologous S cultures. There are "varying degrees of constancy of the R variant"; but by these means it has been possible to effect conversion of all R forms selected. Attempts to cause a further "degradation" of R organisms by continued growth in homologous immune serum have been unsuccessful. Type II S and III S vaccines are equally effective in producing conversion when heated for 15' at 60°C., or for 15' at 100°C. Type I S vaccine, however, while effective in causing conversion when heated for 15' at 60°C., apparently loses this property when heated for 15' at 100°C. R vaccines, and vaccines of other organisms, when injected together with live R cultures, have always failed to produce conversion. The causes responsible for conversion under these experimental conditions are discussed and the possibility of the occurrence of a similar process under natural conditions in human beings is indicated.


Author(s):  
Ronald S. Weinstein ◽  
N. Scott McNutt

The Type I simple cold block device was described by Bullivant and Ames in 1966 and represented the product of the first successful effort to simplify the equipment required to do sophisticated freeze-cleave techniques. Bullivant, Weinstein and Someda described the Type II device which is a modification of the Type I device and was developed as a collaborative effort at the Massachusetts General Hospital and the University of Auckland, New Zealand. The modifications reduced specimen contamination and provided controlled specimen warming for heat-etching of fracture faces. We have now tested the Mass. General Hospital version of the Type II device (called the “Type II-MGH device”) on a wide variety of biological specimens and have established temperature and pressure curves for routine heat-etching with the device.


Author(s):  
G. D. Gagne ◽  
M. F. Miller ◽  
D. A. Peterson

Experimental infection of chimpanzees with non-A, non-B hepatitis (NANB) or with delta agent hepatitis results in the appearance of characteristic cytoplasmic alterations in the hepatocytes. These alterations include spongelike inclusions (Type I), attached convoluted membranes (Type II), tubular structures (Type III), and microtubular aggregates (Type IV) (Fig. 1). Type I, II and III structures are, by association, believed to be derived from endoplasmic reticulum and may be morphogenetically related. Type IV structures are generally observed free in the cytoplasm but sometimes in the vicinity of type III structures. It is not known whether these structures are somehow involved in the replication and/or assembly of the putative NANB virus or whether they are simply nonspecific responses to cellular injury. When treated with uranyl acetate, type I, II and III structures stain intensely as if they might contain nucleic acids. If these structures do correspond to intermediates in the replication of a virus, one might expect them to contain DNA or RNA and the present study was undertaken to explore this possibility.


Sign in / Sign up

Export Citation Format

Share Document